When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Cryptococcosis

最后审阅: 25 Nov 2025
最后更新: 23 May 2025

小结

定义

病史和体格检查

关键诊断因素

  • constitutional symptoms
  • dyspnea
  • productive cough
  • dullness to percussion
  • diminished breath sounds
  • crackles
  • headache
  • alteration of consciousness
  • meningeal irritation
  • papilledema
  • skin lesions
  • coma
完整详情

其他诊断因素

  • chest pain
  • cranial neuropathy
  • ocular manifestations
完整详情

危险因素

  • HIV infection
  • immunosuppression
  • exposure to Cryptococcus species
  • male sex
  • pregnancy and postpartum period
完整详情

诊断性检查

首要检查

  • serum cryptococcal polysaccharide antigen (CrAg)
  • cerebrospinal fluid (CSF) cryptococcal polysaccharide antigen (CrAg)
  • pleural fluid cryptococcal polysaccharide antigen (CrAg)
  • cultures
  • HIV antibodies
  • chest x-ray
  • lumbar puncture
  • cerebrospinal fluid (CSF) microscopy
  • cerebrospinal fluid (CSF) white blood cell count (cells/microliter)
完整详情

需考虑的检查

  • CT chest
  • MRI brain
  • CT brain
  • bronchoscopy
  • biopsy
完整详情

新兴检查

  • cryptococcus polymerase chain reaction (PCR)

治疗流程

持续性治疗

without HIV

with HIV

撰稿人

Authors

Radha Rajasingham, MD

Associate Professor of Medicine

Infectious Diseases and International Medicine

Department of Medicine

University of Minnesota

Minneapolis

MN

Disclosures

RR receives grants from the US National Institutes of Health (NIH) for prevention of cryptococcal meningitis clinical trials. She is a consultant for the Pan American Health Organization for research in histoplasmosis screening. RR is an author of several references cited in this topic.

Acknowledgements

Dr Radha Rajasingham would like to gratefully acknowledge Dr David Boulware, Dr Renata L. Riha, and Dr Athanasia D. Pataka, previous contributors to this topic.

Disclosures

DRB has received research support from Gilead. RLR and ADP declare that they have no competing interests.

Peer reviewers

William Powderly, MD

Professor of Medicine

Washington University in St Louis

St Louis

MO

Disclosures

WP declares that he is a member of advisory boards for Gilead and Merck and his institution has received research grants from Merck; none of these are related to antifungal therapy. WP is a member of the Board of Directors (Past President) of the Infectious Diseases Society of America. WP is an author of a reference cited in this topic.

Ricardo Negroni, MD

Consultant

Muñiz Hospital

Honorary Professor

University of Buenos Aires

Buenos Aires

Argentina

Disclosures

RN declares that he has no competing interests.

Aimee Zaas, MD, MHS

Assistant Professor of Medicine

Division of Infectious Diseases and International Health

Duke University Medical Center

Durham

NC

Declarações

AZ has received research funding from Enzon Pharmaceuticals and has been on the speaker's bureau for Astellas Pharma and Pfizer Inc.

Joseph Jarvis, BSc, MBBS, MRCP

Professor

Department of Clinical Research

Faculty of Infectious and Tropical Diseases

London School of Hygiene and Tropical Medicine

London

UK

Declarações

JJ declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006 Sep;20(3):507-44. Resumo

Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: cryptococcosis. Oct 2024 [internet publication].Texto completo

World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Jun 2022 [internet publication].Texto completo

Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010 Feb 1;50(3):291-322.Texto completo  Resumo

Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014 Jun 26;370(26):2487-98.Texto completo  Resumo

Rolfes MA, Hullsiek KH, Rhein J, et al. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis. Clin Infect Dis. 2014 Dec 1;59(11):1607-14.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Cryptococcosis images
  • Diagnósticos diferenciais

    • Tuberculosis
    • Primary or metastatic central nervous system (CNS) neoplasm
    • Skin manifestations of systemic infections
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: cryptococcosis
    • Global guideline for the diagnosis and management of cryptococcosis
    Mais Diretrizes
  • Videos

    Diagnostic lumbar puncture in adults: animated demonstration

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer